Nan van Geloven on Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
Nan van Geloven, Assistant Professor at Leiden University Medical Center, reposted from JAMA on LinkedIn:
”NEW PAPER
“Regular predictions are not suited for supporting individual treatment decisions. Combining prediction with causal inference is needed instead.”
Telling is one thing, doing is another.
In this new JAMA paper we put our money where our mouth is and applied causal inference to develop and evaluate a prediction model that estimates risks under different treatment options, supporting treatment decisions in preterm infants.
Highly rewarding to get the chance to put our newly developed methods in action, together with a great team of clinicians and epidemiologists.”
JAMA shared on LinkedIn:
”Among preterm infants with severe thrombocytopenia, this modeling study found substantial variation among individuals in predicted benefits and harms of prophylactic platelet transfusion based on their current clinical characteristics.”
Read the full article in JAMA.
Article: Individualized Prediction of Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
Authors: Hilde van der Staaij, Ilaria Prosepe, Camila Caram-Deelder, Ruth H. Keogh, Emöke Deschmann, Christof Dame, Wes Onland, Sandra A. Prins, Florian Cassel, Esther J. d’Haens, Elke van Westering-Kroon, Peter Andriessen, Sabine L. Vrancken, Christian V. Hulzebos, Daniel C. Vijlbrief, Suzanne F. Fustolo-Gunnink, Karin Fijnvandraat, Enrico Lopriore, Johanna G. van der Bom, Nan van Geloven

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability
-
Oct 4, 2026, 13:35Sumyea Kabir: Optimizing Plasma Selection for Therapeutic Plasma Exchange in TTP
-
Oct 4, 2026, 13:31Swati Raikwar: Microplastics as a Threat to Cerebral Blood Flow
-
Oct 4, 2026, 13:18Maria Elisa Mancuso: EHC 2026 Opens with Focus on Haemophilia Care, Access and Rare Disorders
-
Oct 4, 2026, 13:16Anita Brikman: Inside the Plasma Donation Journey
-
Oct 4, 2026, 13:13Overcoming FVIII Inhibitors With Efanesoctocog Alfa – JTH